Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs. Neostigmine for Quality of Recovery in Laparoscopic Cholecystectomy
NCT04332627Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2020
- Primary completion
- May 2020
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Quality of Recovery-15 questionnaire score. Started Feb 2020; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04332627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332627.